dijous, 29 de juny del 2017

MetaStat lands $7m for personalized cancer diagnostic, therapy tech

MetaStatMetaStat (OTC:MTST) said this week that it closed the 1st tranche of a $7 million private placement.

The round, which was led by Perceptive Advisors, is slated to bring in approximately $2.1 million, according to the Boston-based company.

Get the full story at our sister site, Drug Delivery Business News.

The post MetaStat lands $7m for personalized cancer diagnostic, therapy tech appeared first on MassDevice.



from MassDevice http://ift.tt/2tocUib

Cap comentari:

Publica un comentari a l'entrada